Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Upper Limb Rehabilitation in People With Parkinson's Disease:

NCT06906679 · IRCCS San Raffaele Roma · Updated 19 Oct 2026

What is being tested
Experimental Group; control group
For
Parkinson Disease
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 30 years to 80 years. About 42 people. The full rules are on the registry page.
Where
Italy (2 sites)
When
Starts or started 20 Dec 2023, ends 14 Oct 2026. Registered 2 April 2025.
Results
None posted yet.

In the researchers' words

This study evaluates the effectiveness of upper limb rehabilitation using an end-effector robotic device with exercises designed to improve movements, strength, and coordination of the shoulder, elbow, and wrist in patients with Parkinson's disease who have mild to moderate disability, compared to conventional rehabilitation treatment. The study protocol will involve individuals diagnosed with PD according to the UK Parkinson's Disease Society Brain Bank criteria, who will be randomly assigned to one of the following groups: A - Experimental Group (EG) - robotic treatment for upper limb rehabilitation. B - Control Group (CG) - conventional treatment for upper limb rehabilitation. Secondary objectives include: \- Evaluating the effectiveness of an end-effector robotic system in terms of improving upper limb coordination and functionality through the ARAT test and the UPDRS. Identifying subgroups of participants who may benefit more from robotic therapy based on PD disease stage (Hoehn \& Yahr), age, and upper limb impairment. Analyzing the effects of robotic rehabilitation on quality of life. Assessing participants' compliance and satisfaction levels with the robotic system in terms of improving participation in upper limb rehabilitation.
ClinicalTrials.gov, NCT06906679

Sites

  • San Raffaele CassinoCassino, FR, Italy
  • IRCCS San Raffaele RomaRome, Lazio, Italy